Last reviewed · How we verify
NCT04810832: EXPRESON-IN
EXPRESON-IN : Intracerebral Recordings of P3a Responses to Expressive Own-names
NA trial testing Evoked related potentials in Intractable Epilepsy in 20 participants. Status unknown.
9 September 2022
Quick facts
| Lead sponsor | Centre Hospitalier St Anne |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 9 September 2020 |
| Primary completion | 9 September 2022 |
| Estimated completion | 9 September 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Evoked related potentials
Conditions studied
- Intractable Epilepsy — all drugs for Intractable Epilepsy →
Sponsor
Centre Hospitalier St Anne
Who can join
18 and older, any sex, with Intractable Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Neurophysiologic evaluation of disorders of consciousness (DOC) patients in intensive care unit include late auditory evoked potentials. It allows the physicians to record cerebral responses of patients to auditory stimuli and in particularly to their own name (as the P3a response). Numerous studies try to improve the relevance of the auditory stimuli used in this paradigm and notably using more expressive stimuli. Here the investigators investigate the intracerebral correlates of the P3a responses recorded on the scalp with neutral and more expressive stimuli.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04810832
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intractable Epilepsy
Currently open trials in the same condition.
- NCT05600738 — Network Effects of Therapeutic Deep Brain Stimulation · NA · recruiting
Other Centre Hospitalier St Anne trials
Trials by the same sponsor.
- NCT07340736 — Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Corr · NA · not yet recruiting
- NCT07376473 — Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas · not yet recruiting
- NCT07395323 — Impact of Relaxation Sessions Using a Virtual Reality Application on the Sleep Quality of Caregivers Working Night Shift · NA · not yet recruiting
- NCT07283458 — Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS) · NA · not yet recruiting
- NCT07144956 — Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04810832 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier St Anne
- Last refreshed: 9 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04810832.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing